ecancer

ecancer.org

ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.

 

ecancer
I

SABCS 2022 Phase 3 DESTINY-Breast02 Study: T-DXd Efficacy in Patients With HER2+ Unresectable/mBC Previously Treated With T-DM1

By ecancer FEATURING Ian Krop
By ecancer FEATURING Ian Krop
90 views
January 10, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

20:00
Exelixis

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam

Featured Video

21:09
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam
SABCS 2022
06:32
ecancer

SABCS 2022 Genomic Assay and Prediction of Long-Term Prognosis in Pr…

Feat. R. O'Regan
04:05
ecancer

SABCS 2022 Breast Cancer Patients and Interrupted ET to Pursue Pregn…

Feat. C. Saura
03:24
ecancer

SABCS 2022 EMERALD Phase 3 Trial: Elacestrant and PFS in ER+/HER2- m…

Feat. V. Kaklamani
06:53
ecancer

SABCS 2022 Primary Results From the POSITIVE Trial: Interruption of …

Feat. A. Partridge
05:21
ecancer

SABCS 2022 Follow-Up of Patients With Early BC After 30 Years: Radio…

Feat. I. Kunkler
07:12
ecancer

SABCS 2022 Phase 3 DESTINY-Breast02 Study: T-DXd Efficacy in Patient…

Feat. I. Krop
11:02
ecancer

SABCS 2022 Treatment Decision Guided by CTC Count and Long-Term Outc…

Feat. J. Pierga
17:26
ecancer

SABCS 2022 Updates From TAILORx and RxPONDER Trials: Implications fo…

Feat. C. Markopoulos, K. Kalinsky